ZYXI

Zynex Inc

ZYXI, USA

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; and M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, braces for rehabilitation support for knee and wrist, and Dynacomp for cold compression therapy. Further, it develops Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser photoplethysmographic patient monitoring device; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; and fluid monitoring and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

https://www.zynex.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
ZYXI
stock
ZYXI

Zynex stock plummets after filing for Chapter 11 bankruptcy protection Investing.com

Read more →
ZYXI
stock
ZYXI

Zynex stock plummets after filing for Chapter 11 bankruptcy protection By Investing.com Investing.com UK

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$3.7

Analyst Picks

Strong Buy

0

Buy

1

Hold

2

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

-0.54

Low 1

High 3

Return on Equity (ROE)

-

Very High

103.73 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

-94.69 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-47.35 %

Low 5%

High 15%

Investors

* Institutions hold a combined 19.37% of the total shares of Zynex Inc

1.

Vanguard Group Inc

(3.1281%)

since

2025/06/30

2.

Vanguard Total Stock Mkt Idx Inv

(2.2997%)

since

2025/07/31

3.

BlackRock Inc

(2.0116%)

since

2025/06/30

4.

Janney Montgomery Scott LLC

(1.4529%)

since

2025/06/30

5.

Two Sigma Advisers, LLC

(0.9854%)

since

2025/06/30

6.

Arrowstreet Capital Limited Partnership

(0.8176%)

since

2025/06/30

7.

Susquehanna International Group, LLP

(0.7985%)

since

2025/06/30

8.

Two Sigma Investments LLC

(0.7264%)

since

2025/06/30

9.

Millennium Management LLC

(0.7104%)

since

2025/06/30

10.

Geode Capital Management, LLC

(0.6252%)

since

2025/06/30

11.

Renaissance Technologies Corp

(0.5686%)

since

2025/06/30

12.

D. E. Shaw & Co LP

(0.5029%)

since

2025/06/30

13.

RBF LLC

(0.4951%)

since

2025/06/30

14.

Goldman Sachs Group Inc

(0.4814%)

since

2025/06/30

15.

Vanguard Institutional Extnd Mkt Idx Tr

(0.4662%)

since

2025/07/31

16.

Bank of New York Mellon Corp

(0.3818%)

since

2025/06/30

17.

Jane Street Group LLC

(0.3081%)

since

2025/06/30

18.

Fidelity Extended Market Index

(0.2801%)

since

2025/07/31

19.

State Street Corp

(0.2577%)

since

2025/06/30

20.

FMR Inc

(0.2387%)

since

2025/06/30

21.

GSA Capital Partners LLP

(0.2075%)

since

2025/06/30

22.

SIMPLEX TRADING, LLC

(0.1839%)

since

2025/06/30

23.

Northern Trust Corp

(0.1785%)

since

2025/06/30

24.

Bridgeway Ultra-Small Company Market

(0.1267%)

since

2025/06/30

25.

iShares Micro-Cap ETF

(0.116%)

since

2025/08/31

26.

Extended Equity Market Fund K

(0.1134%)

since

2025/06/30

27.

Fidelity Total Market Index

(0.0959%)

since

2025/07/31

28.

Goldman Sachs Absolute Ret Trckr Instl

(0.0849%)

since

2025/06/30

29.

AST Small Cap Value

(0.0828%)

since

2024/11/30

30.

Fidelity Nasdaq Composite Index

(0.0796%)

since

2025/07/31

31.

Fidelity Series Total Market Index

(0.073%)

since

2025/07/31

32.

WisdomTree US SmallCap Earnings ETF

(0.0671%)

since

2025/08/29

33.

Royce Quant Small-Cap Quality Value ETF

(0.0632%)

since

2025/08/29

34.

Northern Trust Extended Eq Market Idx

(0.0587%)

since

2025/06/30

35.

NT Ext Equity Mkt Idx Fd - L

(0.0587%)

since

2025/06/30

36.

Spartan Extended Market Index Pool F

(0.0572%)

since

2025/07/31

37.

Vanguard Instl Ttl Stk Mkt Idx InstlPls

(0.0474%)

since

2025/07/31

38.

Vanguard Instl Ttl Stck Mkt Idx Tr

(0.0474%)

since

2024/12/31

39.

Gest Bout VIII Inver Value Global Fnd FI

(0.045%)

since

2025/08/31

40.

Deep Value International FI

(0.0429%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.1533

Latest Release

Date

2025-09-30

EPS Actual

-1.42

EPS Estimate

-0.1733

EPS Difference

-1.2467

Surprise Percent

-719.3883%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Wide Moat Company(6.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
Strong Momentum(6.5)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(3)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.